Assignee

AGIOS PHARMACEUTICALS INC

US·78 granted patents·43 pending applications·398 citations·filing 2013–2025

Technology mixA61K108 A61P105 C07D88 C07B13 C12Q11 C07C10

Top patents by PatentIndex Score

121 records

0197US11040036B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 22, 2021·7 cites·26 claims
0297US9850277B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·22 cites·16 claims
0397US9682080B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jun 20, 2017·10 cites·30 claims
0497US9579324B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Feb 28, 2017·22 cites·6 claims
0597US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
0696US11793806B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2021·Granted Oct 24, 2023·3 cites·15 claims
0796US10800782B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 13, 2020·8 cites·42 claims
0896US10029987B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jul 24, 2018·9 cites·24 claims
0996US9656999B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·16 cites·4 claims
1096US9474779B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 25, 2016·36 cites·18 claims
1195US10632114B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Apr 28, 2020·6 cites·12 claims
1295US10172864B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 8, 2019·8 cites·21 claims
1395US9980961B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 29, 2018·8 cites·24 claims
1495US9968595B2Pharmaceutical compositions of therapeutically active compoundsAGIOS PHARMACEUTICALS INC·Filed 2015·Granted May 15, 2018·17 cites·22 claims
1595US9751863B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Sep 5, 2017·13 cites·17 claims
1694US11325914B1Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·2 cites·25 claims
1794US10610125B2Methods and compositions for cell-proliferation-related disordersAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
1894US9732062B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 15, 2017·18 cites·6 claims
1993US10329298B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·11 cites·32 claims
2093US9738625B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Aug 22, 2017·16 cites·20 claims
2193US9694013B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·14 cites·17 claims
2292US9458132B2Therapeutic compounds and compositions and their use as PKM2 modulatorsAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 4, 2016·18 cites·25 claims
2390US10730854B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Aug 4, 2020·3 cites·72 claims
2490US10294215B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·32 claims
2590US10028961B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·4 cites·9 claims
2689US12428376B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Sep 30, 2025·0 cites·5 claims
2789US11464775B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 11, 2022·3 cites·21 claims
2889US2025144093A1Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
2988US11919915B2Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·30 claims
3088US11364240B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 21, 2022·4 cites·27 claims
3188US10905692B2Combination therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Feb 2, 2021·3 cites·22 claims
3288US10201543B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Feb 12, 2019·6 cites·20 claims
3388US9982309B2Method for treating cell proliferation related disordersAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·3 cites·14 claims
3488US9889137B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Feb 13, 2018·6 cites·8 claims
3588US2025332161A1Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
3687US12377093B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Aug 5, 2025·0 cites·16 claims
3787US11254652B2Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamideAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Feb 22, 2022·5 cites·8 claims
3887US10717764B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Jul 21, 2020·1 cites·2 claims
3987US10449184B2Pharmaceutical compositions of therapeutically active compoundsAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 22, 2019·4 cites·23 claims
4086US11505538B1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·1 cites·8 claims
4186US10780093B2Methods of treating brain tumors using combination therapyAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Sep 22, 2020·3 cites·29 claims
4286US9724350B2N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancerAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·12 cites·14 claims
4385US10093654B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·3 cites·70 claims
4484US12133853B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Nov 5, 2024·0 cites·25 claims
4584US10434105B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 8, 2019·3 cites·12 claims
4683US10640534B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 5, 2020·2 cites·6 claims
4783US10188656B2Methods of treatment of malignanciesAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 29, 2019·4 cites·8 claims
4883US10017495B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Jul 10, 2018·3 cites·17 claims
4981US11957680B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Apr 16, 2024·0 cites·14 claims
5080US10105369B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 23, 2018·2 cites·24 claims

Showing the top 50 of 121 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when AGIOS PHARMACEUTICALS INC files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →